Esaote to boost imaging IT offering with 3mensio buy
This article was originally published in Clinica
Italian radiology firm Esaote has acquired 3mensio Medical Imaging, in a bid to expand its presence in the healthcare IT market. Genoa-based Esaote has integrated the Dutch advanced visualisation technology developer into its Pie Medical Imaging subsidiary, which is also based in the Netherlands. Financial terms of the deal were not disclosed. 3mensio's 3D/4D visualisation technology is used in endovascular aneurysm repair (EVAR) and for transcatheter aortic valve implantation, to help surgeons plan procedures. Maastricht-based Pie Medical develops quantitative analysis software for cardiology and radiology applications, including its CAAS products. 3mensio's founder and CEO, Frank Wessels, will continue to lead the technical team in the new company, while CEO Paul Sysmans will remain involved as a consultant to the management.
You may also be interested in...
Israel is well-known as a medtech hot-spot, with a focus on academic research and strong government support helping the country punch well above its weight when it comes to innovative devices.
St Jude Medical had a heavy focus on its intravascular imaging offering at this year’s EuroPCR meeting, presenting data supporting its optical coherence tomography (OCT) technology. OCT provides intravascular images to help assess culprit lesions, which can improve stent selection and deployment, according to St Jude.
A big topic at this year’s EuroPCR, held in Paris on 19-22 May, was drug-coated balloons (DCBs). One of the leaders in the field, Medtronic, presented positive data from two studies of its IN.PACT Admiral balloon, which could support an expanded indication for the device.